Interactions of ciprofloxacin with DPPC and DPPG: fluorescence anisotropy, ATR-FTIR and 31P NMR spectroscopies and conformational analysis.
The interactions between a drug and lipids may be critical for the pharmacological activity. We previously showed that the ability of a fluoroquinolone antibiotic, ciprofloxacin, to induce disorder and modify the orientation of the acyl chains is related to its propensity to be expelled from a monolayer upon compression [1]. Here, we compared the binding of ciprofloxacin on DPPC and DPPG liposomes (or mixtures of phospholipids [DOPC:DPPC], and [DOPC:DPPG]) using quasi-elastic light scattering and steady-state fluorescence anisotropy. We also investigated ciprofloxacin effects on the transition temperature (T(m)) of lipids and on the mobility of phosphate head groups using Attenuated Total Reflection Fourier Transform Infrared-Red Spectroscopy (ATR-FTIR) and (31)P Nuclear Magnetic Resonance (NMR) respectively. In the presence of ciprofloxacin we observed a dose-dependent increase of the size of the DPPG liposomes whereas no effect was evidenced for DPPC liposomes. The binding constants K(app) were in the order of 10(5) M(-1) and the affinity appeared dependent on the negative charge of liposomes: DPPG>DOPC:DPPG (1:1; M:M)>DPPC>DOPC:DPPC (1:1; M:M). As compared to the control samples, the chemical shift anisotropy (Deltasigma) values determined by (31)P NMR showed an increase of 5 and 9 ppm for DPPC:CIP (1:1; M:M) and DPPG:CIP (1:1; M:M) respectively. ATR-FTIR experiments showed that ciprofloxacin had no effect on the T(m) of DPPC but increased the order of the acyl chains both below and above this temperature. In contrast, with DPPG, ciprofloxacin induced a marked broadening effect on the transition with a decrease of the acyl chain order below its T(m) and an increase above this temperature. Altogether with the results from the conformational analysis, these data demonstrated that the interactions of ciprofloxacin with lipids depend markedly on the nature of their phosphate head groups and that ciprofloxacin interacts preferentially with anionic lipid compounds, like phosphatidylglycerol, present at a high content in these membranes.
Bensikaddour
Hayet
H
Université Catholique de Louvain, Faculty of Medicine, Unité de Pharmacologie Cellulaire et Moléculaire, UCL 73.70, Avenue E. Mounier 73, B-1200 Bruxelles, Belgium.
Snoussi
Karim
K
Lins
Laurence
L
Van Bambeke
Françoise
F
Tulkens
Paul M
PM
Brasseur
Robert
R
Goormaghtigh
Erik
E
Mingeot-Leclercq
Marie-Paule
MP
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000737:chemistry* / Q000378:metabolism*; D002939:Ciprofloxacin / Q000737:chemistry* / Q000378:metabolism*; D003198:Computer Simulation; D005454:Fluorescence Polarization; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D008968:Molecular Conformation; D010710:Phosphates / Q000737:chemistry; D010715:Phosphatidylglycerols / Q000737:chemistry* / Q000378:metabolism*; D010759:Phosphorus Isotopes; D017550:Spectroscopy, Fourier Transform Infrared; D013696:Temperature; D044366:Transition Temperature; D053835:Unilamellar Liposomes / Q000737:chemistry
D010710:Phosphates; D010715:Phosphatidylglycerols; D010759:Phosphorus Isotopes; D053835:Unilamellar Liposomes; D015060:1,2-Dipalmitoylphosphatidylcholine; D002939:Ciprofloxacin; C030345:1,2-dipalmitoylphosphatidylglycerol